欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/5405/001
药品名称Solifenacin succinate/Tamsulosin hydrochloride CF 6 mg/0.4 mg modified-release tablets
活性成分
    • solifenacin succinate 6.0 mg
    • tamsulosin hydrochloride 0.4 mg
剂型Modified-release tablet
上市许可持有人Centrafarm B.V. Van De Reijtstraat 31 E 4814 NE Breda The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Solifenacinesuccinaat/Tamsulosinehydrochloride CF 6 mg/0,4 mg, tabletten met gereguleerde afgifte
互认成员国 - 产品名称
    • Ireland (IE)
    • Austria (AT)
    • Spain (ES)
    • Portugal (PT)
    • Norway (NO)
    • Finland (FI)
    • Czechia (CZ)
      Noctera
    • Croatia (HR)
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
      Solifenacine/Tamsulosine EG, 6mg/0,4 mg tabletten met gereguleerde afgifte
    • Luxembourg (LU)
许可日期2023/04/26
最近更新日期2024/05/08
药物ATC编码
    • G04CA53 tamsulosin and solifenacin
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase